Paul Richardson, MD: Current Therapies for Multiple Myeloma
Interviewed by Steven Greer, MD
Dr. Paul Richardson, Clinical Director of the Multiple Myeloma Center at Harvard’s Dana-Farber Cancer Institute gives an overview of the current standard of care for patients with multiple myeloma
Harvard affiliates, Oncology, Stem cells, The Lancet | apples49 | 
August 16, 2013 9:46 pm
No Comments
No comments yet.
Notice: comments_rss_link is deprecated since version 2.5! Use post_comments_feed_link() instead. in /data/30/1/121/80/1121895/user/1185656/htdocs/wordpress/wp-includes/functions.php on line 3406
RSS feed for comments on this post.
TrackBack URI
